Changes in clinical trial length

descriptionPublicationkeyboard_double_arrow_right Article 30 Apr 2015 Australia English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 14, pages 307-308 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Pregelj, Lisette; Verreynne, Martie-Louise; Hine, Damian;

doi: 10.1038/nrd4611

pmid: 25924577

Changes in clinical trial length

- Summary
- Subjects
- Metrics

Abstract

This analysis of changes in the length of clinical trials over time provides evidence of increased efficiency in drug development and investigates the possible contributing factors.

Country

Australia

Related Organizations

Keywords

Clinical Trials as Topic, Time Factors, Biotechnology & Applied Microbiology, Research Design, Drug Design, Humans, Regression Analysis, Pharmacology & Pharmacy

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	8
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%